Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...
As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.
Hosted on MSN
New weekly injectable drug could transform the lives of people living with Parkinson’s disease
A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...
Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...
New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
Both companies now aim to win in the oral weight loss drug market.
The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky ...
Depot medroxyprogesterone acetate (DMPA) can prevent pregnancy for up to three months, and is available in a form that can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback